Topical Mastic Oil for Treatment of Functional Dyspepsia: A Randomized Triple-Blind Controlled Trial

被引:5
|
作者
Sattarzadeh, Mahsa Baradaran [1 ]
Shojaii, Asie [2 ]
Toosi, Mohssen Nassiri [3 ]
Abdollahi-Fard, Mehri [2 ]
Avanaki, Foroogh Alborzi [3 ]
Taher, Mohammad [3 ]
Shiehmorteza, Maryam [1 ]
Hashem-Dabaghian, Fataneh [2 ]
机构
[1] Islamic Azad Univ, Tehran Univ Med Sci, Fac Pharm & Pharmaceut Sci, Dept Clin Pharm, Tehran, Iran
[2] Iran Univ Med Sci, Sch Persian Med, Res Inst Islamic & Complementary Med, Tehran, Iran
[3] Univ Tehran Med Sci, Imam Khomeini Hosp, Dept Gastroenterol, Tehran, Iran
来源
GALEN MEDICAL JOURNAL | 2021年 / 10卷
关键词
Functional Dyspepsia; Persian Medicine; Herbal Medicine; Clinical Trial; Mastic; VALIDATION; DISORDERS; SEVERITY; SYMPTOMS; GUM;
D O I
10.31661/gmj.v10i0.1965
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
Background: The main goal of the present study was to evaluate the effect of topical mastic oil, compared to placebo on treatment of functional dyspepsia (FD). Materials and Methods: Sixty-three patients with FD were included. Thirty-two subjects received the topical mastic oil (10 drops/TDS after meal) with massage and 31 patients received topical sesame oil with massage. Both groups received pantoprazole (40 mg daily) along with oil and massage. The severity of early satiation, postprandial fullness, epigastric pain and epigastric burning was assessed after 4 weeks using the Visual Analogue Scale (VAS) as well as frequency of symptoms. Satisfaction with the treatment was also assessed using a researcher-made questionnaire. Changes in the severity of symptoms were evaluated by Friedman's test. Results: Mean and standard deviation of age of the subjects were equal to 36.95 +/- 13.64 and 50 (79.4%) patients were female. Both groups experienced a significant decrease in the severity of all the four symptoms (P<0.001). The percentage of decrease in the severity of early satiation was significantly higher in the mastic group than the control group (76.03 +/- 34.91% vs. 37.24 +/- 38.86%, P=0.003). No significant differences were found in the percentage of decrease in the severity of postprandial fullness, epigastric pain and burning between the study groups (P=0.05, 0.06, and 0.13, respectively). The frequency of symptoms was decreased similarly in both groups. Satisfaction with the treatment was reported to be significantly higher in the mastic group than the sesame group (P=0.01). There were no intolerable side effects in both groups. Conclusion: Mastic oil reduced early satiation better than the placebo. In addition, satisfaction with the treatment was higher in the mastic group than the sesame group.
引用
收藏
页数:11
相关论文
共 50 条
  • [31] Melatonin Treatment in Patients with Burning Mouth Syndrome: A Triple-Blind, Placebo-Controlled, Crossover Randomized Clinical Trial
    Varoni, Elena M.
    Lo Faro, Alfredo F.
    Lodi, Giovanni
    Carrassi, Antonio
    Iriti, Marcello
    Sardella, Andrea
    JOURNAL OF ORAL & FACIAL PAIN AND HEADACHE, 2018, 32 (02) : 178 - 188
  • [32] Favipiravir in the Treatment of Outpatient COVID-19: A Multicenter, Randomized, Triple-Blind, Placebo-Controlled Clinical Trial
    Vaezi, Atefeh
    Salmasi, Mehrzad
    Soltaninejad, Forogh
    Salahi, Mehrdad
    Javanmard, Shaghayegh Haghjooy
    Amra, Babak
    ADVANCES IN RESPIRATORY MEDICINE, 2023, 91 (01) : 18 - 25
  • [33] Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial
    Giannini, I.
    Amato, A.
    Basso, L.
    Tricomi, N.
    Marranci, M.
    Pecorella, G.
    Tafuri, S.
    Pennisi, D.
    Altomare, D. F.
    TECHNIQUES IN COLOPROCTOLOGY, 2015, 19 (06) : 339 - 345
  • [34] CURRENT MANAGEMENT OF SHOULDER ADHESIVE CAPSULITIS: A RANDOMIZED, TRIPLE-BLIND PLACEBO-CONTROLLED TRIAL
    Almashni, Riyadh
    Calacattawi, Abdullah
    Almeshal, Meshal
    Alsharif, Elaf
    Hijazi, Mohamad
    Abdulwahab, Shahd
    Alsharif, Anfal
    al Tufayl, Nasser Omair
    Alghamdi, Anwar
    Almuzayyen, Hisham
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (02): : 3537 - 3544
  • [35] Flavonoids mixture (diosmin, troxerutin, hesperidin) in the treatment of acute hemorrhoidal disease: a prospective, randomized, triple-blind, controlled trial
    I. Giannini
    A. Amato
    L. Basso
    N. Tricomi
    M. Marranci
    G. Pecorella
    S. Tafuri
    D. Pennisi
    D. F. Altomare
    Techniques in Coloproctology, 2015, 19 : 339 - 345
  • [36] Simvastatin in the Prevention of Recurrent Pancreatitis: Design and Rationale of a Multicenter Triple-Blind Randomized Controlled Trial, the SIMBA Trial
    Cardenas-Jaen, Karina
    Vaillo-Rocamora, Alicia
    Gracia, Angel
    Garg, Pramoud K.
    Zapater, Pedro
    Papachristou, Georgios I.
    Singh, Vikesh K.
    Wu, Bechien U.
    de-Madaria, Enrique
    FRONTIERS IN MEDICINE, 2021, 7
  • [37] Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial
    Hui Zheng
    Xiao-ping Tian
    Ying Li
    Fan-rong Liang
    Shu-guang Yu
    Xu-guang Liu
    Yong Tang
    Xu-guang Yang
    Jie Yan
    Guo-jie Sun
    Xiao-rong Chang
    Hong-xing Zhang
    Ting-ting Ma
    Shu-yuan Yu
    Trials, 10
  • [38] Acupuncture as a treatment for functional dyspepsia: design and methods of a randomized controlled trial
    Zheng, Hui
    Tian, Xiao-ping
    Li, Ying
    Liang, Fan-rong
    Yu, Shu-guang
    Liu, Xu-guang
    Tang, Yong
    Yang, Xu-guang
    Yan, Jie
    Sun, Guo-jie
    Chang, Xiao-rong
    Zhang, Hong-xing
    Ma, Ting-ting
    Yu, Shu-yuan
    TRIALS, 2009, 10
  • [39] Acute Effect of Topical Menthol on Chronic Pain in Slaughterhouse Workers with Carpal Tunnel Syndrome: Triple-Blind, Randomized Placebo-Controlled Trial
    Sundstrup, Emil
    Jakobsen, Markus D.
    Brandt, Mikkel
    Jay, Kenneth
    Colado, Juan Carlos
    Wang, Yuling
    Andersen, Lars L.
    REHABILITATION RESEARCH AND PRACTICE, 2014, 2014
  • [40] Topical terbinafine in the treatment of cutaneous leishmaniasis: triple blind randomized clinical trial
    Farajzadeh S.
    Heshmatkhah A.
    Vares B.
    Mohebbi E.
    Mohebbi A.
    Aflatoonian M.
    Eybpoosh S.
    Sharifi I.
    Aflatoonian M.R.
    Shamsi Meymandi S.
    Fekri A.R.
    Mostafavi M.
    Journal of Parasitic Diseases, 2016, 40 (4) : 1159 - 1164